SafKan - Ear Care
SafKan - Ear Care is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at SafKan - Ear Care.
SafKan - Ear Care is a company.
Key people at SafKan - Ear Care.
Key people at SafKan - Ear Care.
SafKan Health (also referred to as SafKan - Ear Care) is a Seattle-based medical device startup developing the OtoSet® Ear Cleaning System, the world's first FDA-cleared automated ear cleaning device for cerumen (earwax) removal. It targets healthcare providers and patients affected by earwax buildup, impacting 35 million Americans annually—including 1 in 10 children, 1 in 20 adults, and over one-third of seniors—by replacing messy manual methods like syringes with a safe, efficient, wearable headphone-like system using patented irrigation and micro-suction technology.[1][2][3][4][5] The device serves audiologists, hearing care retailers like Beltone, and clinics, solving problems of clinical inefficiency, patient discomfort, referral delays, and hearing aid damage from wax, while reducing procedure time from 20 minutes to under 5 minutes with mess-free, single-use tips and automated cycles.[1][2][5][7] Backed by $13 million in funding, including an $8M Series A led by Unorthodox Ventures, SafKan has gained traction through partnerships, awards like the Hearing Technology Innovator Award (2021, 2023), and Fast Company's 2023 Innovation by Design recognition, positioning it for expanded clinical adoption.[2][3][5][7]
SafKan Health emerged as a medical device startup in Seattle, WA (with headquarters listed in Redmond), founded by Co-Founder & CEO Sahil Diwan, who identified the need to modernize earwax management amid outdated tools like ear syringes and buckets.[2][4][5] The idea stemmed from addressing excessive earwax—a common issue causing hearing aid damage and specialist referrals—for over 231,000 weekly U.S. physician visits, leading to the development of OtoSet®, which secured FDA clearance in 2020.[1][2][4] Early milestones included a $1M raise for U.S. hospital launch, viral media buzz (e.g., TikTok, Gizmodo), and the 2021 Hearing Technology Innovator Award, followed by the $8M Series A in partnership with Unorthodox Ventures' Carey Smith, bringing total funding to $13M and enabling market debut.[3][5] A pivotal 2022 partnership with Beltone, the leading U.S. hearing care retailer, rolled out OtoSet® nationwide, marking initial commercial traction.[2]
SafKan stands out in ear care through OtoSet®'s breakthrough features:
SafKan rides the medtech automation wave, modernizing routine procedures in a $multi-billion hearing health market strained by aging populations (e.g., two-thirds of nursing home residents affected) and clinician shortages.[1][2][5] Timing aligns with post-COVID demand for efficient, contactless tools and FDA's support for digital health innovations, amplified by telehealth growth and hearing aid OTC deregulation.[2][3] Favorable forces include rising earwax-related visits (231K/week), hearing aid adoption, and investor interest in "unsexy" problems via firms like Unorthodox Ventures, which back transformative hardware.[3][5] SafKan influences the ecosystem by setting a new standard for automated cerumen management, potentially reducing specialist burdens, improving access in retail clinics, and inspiring similar devices for other minor procedures.[1][2][7]
SafKan Health is primed for scale with OtoSet®'s validated tech, funding, and partnerships, likely expanding to more hearing centers, nursing homes, and international markets amid demographics driving ear care demand.[2][3][5] Trends like AI-enhanced diagnostics, subscription-based clinic services, and medtech consolidation will shape growth, with potential acquisitions by hearing giants (e.g., Sonova, WS Audiology) boosting reach.[3] Its influence may evolve from niche innovator to category leader, transforming ear care from analog drudgery to automated standard—echoing its mission to enhance patient outcomes and clinical efficiency for millions.[1][2]
